Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer
Meichun Hu(Hubei University of Science and Technology), Zhengfang Yi(Shanghai Changning Maternity and Infant Health Hospital)
Cited by 76
Related Papers
Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression
|Nature Cell Biology|2021|537
Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers
|Frontiers in Oncology|2023|110
Indirubin inhibits tumor growth by antitumor angiogenesis <i>via</i> blocking VEGFR2‐mediated JAK/STAT3 signaling in endothelial cell
|International Journal of Cancer|2011|86
A Natural Small Molecule Harmine Inhibits Angiogenesis and Suppresses Tumour Growth through Activation of p53 in Endothelial Cells
|PLoS ONE|2012|76
Lycorine inhibits glioblastoma multiforme growth through EGFR suppression
|Journal of Experimental & Clinical Cancer Research|2018|61